13F-HR filed by VHCP Management, LLC
VHCP Management, LLC filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-13, with 17 holding rows worth $187,105,000.
- Accession
- 0000950123-14-008686
- Filer
- CIK 1479355
- Filed
- 2014-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2014
A holdings report, 17 entries on the cover page, a total value of $187,105,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $187,105,000 with VALUE read as thousands by filing date, 13F file number 028-14329. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 311,853 | $33,459,000 | thousands by filing date | |
| ANACOR PHARMACEUTICALS INC | 032420101 | COM | 1,545,999 | $27,411,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,744,356 | $22,241,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 2,000,859 | $19,208,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,095,734 | $13,499,000 | thousands by filing date | |
| DBV Technologies | F2927N109 | COM | 480,000 | $12,451,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 700,273 | $10,770,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 541,480 | $10,710,000 | thousands by filing date | |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 500,000 | $7,500,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469108 | COMMON STOCK | 525,000 | $6,825,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 703,730 | $5,376,000 | thousands by filing date | |
| OHR PHARMACEUTICAL INC | 67778H200 | COMMON STOCK | 477,000 | $4,536,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 303,503 | $4,502,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 846,500 | $3,742,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 100,000 | $2,875,000 | thousands by filing date | |
| Alexza Pharmaceuticals Inc | 015384100 | COM | 247,812 | $1,133,000 | thousands by filing date | |
| LIPOCINE INC NEW | 53630X104 | CMN | 142,100 | $867,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-14-008686 | this filing | 2014-08-13 | acceptance time not in the bulk data set |